FGF-2 increases colony formation, PTH receptor, and IGF-1 mRNA in mouse marrow stromal cells

Area of Science:

• Bone biology
• Cellular and molecular medicine
• Regenerative medicine

Background:

• Fibroblast Growth Factor-2 (FGF-2) is known to stimulate bone formation in rats.
• Limited studies exist on FGF-2's effects in mice, and its bone formation mechanisms are not fully understood.
• Investigating FGF-2's impact on osteoblast differentiation in mice is crucial.

Purpose of the Study:

• To determine if short-term FGF-2 treatment enhances osteoblast maturation in mouse marrow stromal cells.
• To investigate the molecular mechanisms underlying FGF-2-induced bone formation in vitro.
• To assess the expression of key osteogenic genes following FGF-2 exposure.

Main Methods:

• Mouse marrow stromal cells were cultured for 14 or 21 days.
• Short-term treatment with varying concentrations of FGF-2 (0.01-1.0 nM) was applied during the initial 3 days of culture.
• Alkaline phosphatase-positive (ALP) mineralized colony formation and gene expression (type 1 collagen, osteocalcin, runt domain/core binding factor, PTH/PTHR receptor, IGF-1) were quantified.

Main Results:

• Short-term FGF-2 treatment significantly increased the number of ALP-positive mineralized colonies.
• FGF-2 (0.1 nM) upregulated the mRNA expression of key osteoblast maturation genes, including type 1 collagen, osteocalcin, and IGF-1.
• Gene expression changes were observed at both 14 and 21 days of culture.

Conclusions:

• Short-term FGF-2 treatment effectively enhances osteoblast maturation in vitro using mouse marrow stromal cells.
• The anabolic effects of FGF-2 on bone formation appear to be partly mediated by the regulation of Insulin-like Growth Factor 1 (IGF-1).
• These findings provide insights into the mechanisms of FGF-2 in bone regeneration and suggest potential therapeutic applications.